
Pursuing the PFAS Problem
Tackling the challenges of “forever chemicals” in the diagnostics industry.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.
A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.
Key approvals announced in June represented important steps forward for the lab testing industry.
The agency recently announced it will decide in December whether to grant clearance for a CRISPR therapy for treating sickle cell disease.